These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 16541250

  • 41. Thermodynamic Characterization of Hydration Sites from Integral Equation-Derived Free Energy Densities: Application to Protein Binding Sites and Ligand Series.
    Güssregen S, Matter H, Hessler G, Lionta E, Heil J, Kast SM.
    J Chem Inf Model; 2017 Jul 24; 57(7):1652-1666. PubMed ID: 28565907
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. A Structure-Activity Relationship Study of Imidazole-5-Carboxylic Acid Derivatives as Angiotensin II Receptor Antagonists Combining 2D and 3D QSAR Methods.
    Sharma MC.
    Interdiscip Sci; 2016 Mar 24; 8(1):1-10. PubMed ID: 26202941
    [Abstract] [Full Text] [Related]

  • 44. Quantitative structure-activity relationships of selective antagonists of glucagon receptor using QuaSAR descriptors.
    Manoj Kumar P, Karthikeyan C, Hari Narayana Moorthy NS, Trivedi P.
    Chem Pharm Bull (Tokyo); 2006 Nov 24; 54(11):1586-91. PubMed ID: 17077558
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Receptor-based 3D-QSAR in Drug Design: Methods and Applications in Kinase Studies.
    Fang C, Xiao Z.
    Curr Top Med Chem; 2016 Nov 24; 16(13):1463-77. PubMed ID: 26369822
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. 3D-QSAR comparative molecular field analysis on opioid receptor antagonists: pooling data from different studies.
    Peng Y, Keenan SM, Zhang Q, Kholodovych V, Welsh WJ.
    J Med Chem; 2005 Mar 10; 48(5):1620-9. PubMed ID: 15743203
    [Abstract] [Full Text] [Related]

  • 55. Comparative binding energy analysis considering multiple receptors: a step toward 3D-QSAR models for multiple targets.
    Murcia M, Morreale A, Ortiz AR.
    J Med Chem; 2006 Oct 19; 49(21):6241-53. PubMed ID: 17034130
    [Abstract] [Full Text] [Related]

  • 56. Docking, 3D-QSAR studies and in silico ADME prediction on c-Src tyrosine kinase inhibitors.
    Tintori C, Magnani M, Schenone S, Botta M.
    Eur J Med Chem; 2009 Mar 19; 44(3):990-1000. PubMed ID: 18722033
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Quantitative structure-activity relationship (QSAR) study of interleukin-1 receptor associated kinase 4 (IRAK-4) inhibitor activity by the genetic algorithm and multiple linear regression (GA-MLR) method.
    Pourbasheer E, Riahi S, Ganjali MR, Norouzi P.
    J Enzyme Inhib Med Chem; 2010 Dec 19; 25(6):844-53. PubMed ID: 20429783
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.